top of page
Browse by category
Search
EASO recommends semaglutide and tirzepatide as first-line treatment for obesity
Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to...
TORe is safe and effective treatment for patients with medically refractory dumping syndrome
Transoral outlet reduction (TORe), a minimally invasive endoscopic procedure that reduces the size of the gastrojejunal anastomosis (GJA)...
Researchers identify key brain receptor mechanism for appetite and weight control
Researchers at Leipzig University and Charité—Universitätsmedizin Berlin have discovered a key mechanism for appetite and weight control,...
Journal watch 1/10/2025
Welcome to our regular round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Fractyl’s REMAIN-1 study shows Revita maintained weight loss after GLP-1 discontinuation
Fractyl Health has revealed results from the REMAIN-1 Midpoint Cohort, supporting the potential for Revita to be the first therapy to...
AI body composition measurements have the potential to predict cardiometabolic risk
A study by researchers at Mass General Brigham and their colleagues, has found that an artificial intelligence (AI) tool designed to...
Browse by tag
bottom of page